GENPREX - 53 Year Dividend History | GNPX
Historical dividend payout and yield for GENPREX (GNPX) since 1971. The current TTM dividend payout for GENPREX (GNPX) as of November 21, 2024 is $0.00. The current dividend yield for GENPREX as of November 21, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.010B |
$0.000B |
|
Genprex Inc. operates as a biotechnology company. It discovers and develops immunogene therapies for cancer treatment as well as clinical research, gene therapies, consulting and other related medical services. The company's initial product candidate is Oncoprex(TM) immunogene therapy which treats non-small cell lung cancer. Genprex Inc. is based in United States.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
